Zymosan-induced glycerylprostaglandin and prostaglandin synthesis in resident peritoneal macrophages: roles of cyclo-oxygenase-1 and -2.

COX [cyclo-oxygenase; PG (prostaglandin) G/H synthase] oxygenates AA (arachidonic acid) and 2-AG (2-arachidonylglycerol) to endoperoxides that are converted into PGs and PG-Gs (glycerylprostaglandins) respectively. In vitro, 2-AG is a selective substrate for COX-2, but in zymosan-stimulated peritoneal macrophages, PG-G synthesis is not sensitive to selective COX-2 inhibition. This suggests that COX-1 oxygenates 2-AG, so studies were carried out to identify enzymes involved in zymosan-dependent PG-G and PG synthesis. When macrophages from COX-1-/- or COX-2-/- mice were treated with zymosan, 20-25% and 10-15% of the PG and PG-G synthesis observed in wild-type cells respectively was COX-2 dependent. When exogenous AA and 2-AG were supplied to COX-2-/- macrophages, PG and PG-G synthesis was reduced as compared with wild-type cells. In contrast, when exogenous substrates were provided to COX-1-/- macrophages, PG-G but not PG synthesis was reduced. Product synthesis also was evaluated in macrophages from cPLA(2alpha) (cytosolic phospholipase A2alpha)-/- mice, in which zymosan-induced PG synthesis was markedly reduced, and PG-G synthesis was increased approx. 2-fold. These studies confirm that peritoneal macrophages synthesize PG-Gs in response to zymosan, but that this process is primarily COX-1-dependent, as is the synthesis of PGs. They also indicate that the 2-AG and AA used for PG-G and PG synthesis respectively are derived from independent pathways.

[1]  L. Marnett,et al.  Simultaneous analysis of prostaglandin glyceryl esters and prostaglandins by electrospray tandem mass spectrometry. , 2005, Analytical biochemistry.

[2]  Lawrence J Marnett,et al.  Glycerylprostaglandin Synthesis by Resident Peritoneal Macrophages in Response to a Zymosan Stimulus* , 2005, Journal of Biological Chemistry.

[3]  Lawrence J. Marnett,et al.  Cyclooxygenase-1-dependent Prostaglandin Synthesis Modulates Tumor Necrosis Factor-α Secretion in Lipopolysaccharide-challenged Murine Resident Peritoneal Macrophages* , 2004, Journal of Biological Chemistry.

[4]  H. Zhang,et al.  Rescue of Female Infertility from the Loss of Cyclooxygenase-2 by Compensatory Up-regulation of Cyclooxygenase-1 Is a Function of Genetic Makeup* , 2004, Journal of Biological Chemistry.

[5]  J. Morrow,et al.  The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. Marnett,et al.  Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide. , 2003, Biochemistry.

[7]  Lawrence J Marnett,et al.  Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases. , 2003, Chemical reviews.

[8]  L. Marnett,et al.  Analysis of endocannabinoids by Ag+ coordination tandem mass spectrometry. , 2003, Analytical biochemistry.

[9]  J. Morrow,et al.  Metabolism of the Endocannabinoids, 2-Arachidonylglycerol and Anandamide, into Prostaglandin, Thromboxane, and Prostacyclin Glycerol Esters and Ethanolamides* , 2002, The Journal of Biological Chemistry.

[10]  Takao Shimizu,et al.  Localization and regulation of cytosolic phospholipase A(2). , 2000, Biochimica et biophysica acta.

[11]  L. Marnett,et al.  Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2* , 2000, The Journal of Biological Chemistry.

[12]  C. Leslie,et al.  Cytosolic Phospholipase A2 Is Required for Macrophage Arachidonic Acid Release by Agonists That Do and Do Not Mobilize Calcium , 2000, The Journal of Biological Chemistry.

[13]  G. FitzGerald,et al.  Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation. , 2000, The Journal of clinical investigation.

[14]  E. Dennis,et al.  Phospholipase A2 in eicosanoid generation. , 2000, American journal of respiratory and critical care medicine.

[15]  L. Marnett,et al.  Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Bonventre,et al.  Cytosolic Phospholipase A 2 Is Required for Macrophage Arachidonic Acid Release by Agonists That Do and Do Not Mobilize Calcium NOVEL ROLE OF MITOGEN-ACTIVATED PROTEIN KINASE PATHWAYS IN CYTOSOLIC PHOSPHOLIPASE A 2 REGULATION* , 2000 .

[17]  R. Garavito,et al.  Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.

[18]  R. Kulmacz,et al.  Hydroperoxide Dependence and Cooperative Cyclooxygenase Kinetics in Prostaglandin H Synthase-1 and -2* , 1999, The Journal of Biological Chemistry.

[19]  A. Mulichak,et al.  The Role of Arginine 120 of Human Prostaglandin Endoperoxide H Synthase-2 in the Interaction with Fatty Acid Substrates and Inhibitors* , 1999, The Journal of Biological Chemistry.

[20]  C. Leslie,et al.  Regulation of arachidonic acid release and cytosolic Phospholipase A2 activation , 1999, Journal of leukocyte biology.

[21]  J. Vane,et al.  Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.

[22]  J. Miyazaki,et al.  Role of cytosolic phospholipase A2 in allergic response and parturition , 1997, Nature.

[23]  M. Moskowitz,et al.  Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2 , 1997, Nature.

[24]  C. Bayly,et al.  The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs. , 1997, Molecular pharmacology.

[25]  C. Ramesha,et al.  Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2* , 1997, The Journal of Biological Chemistry.

[26]  R. Kurumbail,et al.  Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents , 1997, Nature.

[27]  William L. Smith,et al.  Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2* , 1996, The Journal of Biological Chemistry.

[28]  J. Chow,et al.  Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2 , 1996, Nature Structural Biology.

[29]  James M. Carpenter,et al.  ON SIMULTANEOUS ANALYSIS , 1996, Cladistics : the international journal of the Willi Hennig Society.

[30]  Ke-He Ruan,et al.  Role of Val509 in Time-dependent Inhibition of Human Prostaglandin H Synthase-2 Cyclooxygenase Activity by Isoform-selective Agents* , 1996, The Journal of Biological Chemistry.

[31]  H. Herschman Prostaglandin synthase 2. , 1996, Biochimica et biophysica acta.

[32]  William L. Smith,et al.  Fatty Acid Substrate Specificities of Human Prostaglandin-endoperoxide H Synthase-1 and −2 , 1995, The Journal of Biological Chemistry.

[33]  P. Loll,et al.  The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1 , 1994, Nature.

[34]  T. Hla,et al.  Human cyclooxygenase-2 cDNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  V. Winn,et al.  cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[36]  B. Varnum,et al.  TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. , 1991, The Journal of biological chemistry.

[37]  R. Erikson,et al.  Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  N. Pawlowski,et al.  Resting macrophages produce distinct metabolites from exogenous arachidonic acid , 1982, The Journal of experimental medicine.

[39]  F. Kuehl,et al.  Regulation of prostaglandin synthesis and of the selective release of lysosomal hydrolases by mouse peritoneal macrophages. , 1978, The Biochemical journal.

[40]  M. Hamberg,et al.  Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Nugteren,et al.  Isolation and properties of intermediates in prostaglandin biosynthesis. , 1973, Biochimica et biophysica acta.

[42]  M. Hamberg,et al.  Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Z. Cohn,et al.  THE IN VITRO DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES , 1965, The Journal of experimental medicine.

[44]  Z. Cohn,et al.  THE IN VITRO DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES , 1965, The Journal of experimental medicine.

[45]  Z. Cohn,et al.  THE IN VITRO DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES , 2003 .